Table 2.
Sample characteristics and cardiac illness description in 30 pediatric patients with an ICD
| No. of patients included | 30 |
| Age at implant (years) | 13.7 ± 3.6a (range 4.8–22.4) |
| Sex (male/female) | 15/15 |
| Weight (kg) at implant | 48.4 ± 17.0 (range 15–94) |
| Height (cm) at implant | 160.3 ± 19.5 (range 105–190) |
| Beta-blockers used (no.) | 19 |
| ICD indication | |
| SCD survivor | 13 |
| Primary prevention | 17 |
| Cardiovascular disease | |
| Cardiomyopathy | 6 |
| Primary electrical disease | 17 |
| Congenital | 7 |
| Implant characteristics | |
| Epicardial/transvenous approach | 2/28 |
| Single/dual chamber | 26/4 |
| Generator abdominal/subpectoral | 4/26 |
| DFT at implant (mean) | 15.1 ± 5.7 |
| Follow-up | |
| Follow-up after implantation (y) | 3.6 ± 2.6 |
SCD sudden cardiac death, DFT defibrillation threshold
aPlus–minus values are expressed as mean ± SD